SOURCE: Endo Pharmaceuticals

February 15, 2007 10:30 ET

Endo Pharmaceuticals to Hold Conference Call on Fourth Quarter and Full-Year 2006 Financial Results

CHADDS FORD, PA -- (MARKET WIRE) -- February 15, 2007 -- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, will announce its financial results for the fourth quarter and full year ended December 31, 2006 before the market opens on Thursday, February 22, 2007, and will hold a conference call at 11:00 a.m. ET that day to discuss those results. Peter A. Lankau, president and chief executive officer, and Charles A. Rowland, executive vice president and chief financial officer, will host the call.

Investors and other interested parties may access the conference call as follows:

Telephone Numbers

(866) 362-5158 (domestic), (617) 597-5397 (international)

Please dial in 10 minutes prior to the scheduled start time and reference conference code 35562806.


A replay of the call will be available from February 22 at 1:00 p.m. ET by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 87058859, and will run until 12:00 a.m. ET on March 1, 2007.


A simultaneous webcast of the call for interested investors and others may be accessed by visiting In addition, a replay of the webcast will be available until 12:00 a.m. ET on March 1, 2007. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at